Personalized Cancer Diagnosis & Therapy…
Radio-Isotope Therapy of America Foundation is a non-profit charitable organization established in Houston, Texas in 2004. We
believe cancer therapy should be targeted to only cancer cells, and should have minimal effect on normal organs, thus RITA research
and studies focus on “Personalized Cancer Diagnosis and Therapy”. RITA Foundation has initiatives in both clinical and
research area to fight against cancer.
Rita Supports For Cancer Treatment
RITA Foundation of Houston announces support for newly authorized investigational trial to treat patients with metastatic Castration
Resistant prostate cancer (mCRPC). Actinium (Ac)225-PSMA is a new and innovative Targeted Alpha Therapy (TAT) that is
used under FDA authorized Investigational New Drug (IND) application. This clinical trial is currently conducted at Excel Diagnostics
and Nuclear Oncology Center in Houston. Metastatic CRPC is one o f the most aggressive form of prostate cancer and
patients have limited therapeutic options. While there are about 2.2 million men in t he United States living with prostate cancer,
about 43,000 men suffer from this terminal condition. Prostate cancer is the 2nd most common cause of cancer death in men, in
the United States. We are hopeful that our support will bring new and effective treatments for this catastrophic illness.Recruitment
of patients has started on the above treatment. For further information please contact Mrs. Susan Cork at : scork@exceldiagnostics.
com or call: 713-341-3203.
Click Here To Learn More About “Metastatic Castration Resistant Prostate Cancer” Treatment